VEGFA and neoplasm: On the basis of prognostic data gathered from analysis of the tumour vasculature seen in CT scans of patients with advanced ovarian cancer treated with conventional cytotoxic therapy (O’Connor et al, 2007), together with ongoing comparisons between dynamic CT and DCE-MRI, it is likely that there will be an expansion in research to assess whether these techniques can serve as predictive biomarkers in patients treated with VEGF inhibitors.